Danaher stock is making inroads to retaking its 50-day line Tuesday after the medical powerhouse delivered a "solid" first-quarter report and maintained its outlook for the year. The S&P 500 ...

Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments ...

Danaher is down 10.7% during the same time and is heading into earnings with an average analyst price target of $255.02 (compared to the current share price of $186.83).

April 22 (Reuters) - Danaher (DHR.N), opens new tab beat Wall Street estimates for first-quarter profit on Tuesday, on the back of better-than-expected demand for its respiratory testing kits ...

Danaher Corporation’s DHR first-quarter 2025 adjusted earnings of $1.88 per share beat the Zacks Consensus Estimate of $1.62. However, the bottom line decreased 2.1% year over year. Danaher ...

Diversified science and technology company Danaher (NYSE:DHR) will be announcing earnings results tomorrow morning. Here’s what to look for. Danaher beat analysts’ revenue expectations by 1.6% ...